Beruflich Dokumente
Kultur Dokumente
• MISC:
Hypersensitivity reactions,
vasculitis
DRUG NAME DOSAGE MECHANISM OF INDICATION CONTRA- ADVERSE REACTIONS NURSING
ACTION INDICATION RESPONSIBILITIES
Flutocasone Fluticasone Glucocorticoid with a It is used by Known Candidiasis or dryness of ASSESSMENT
inhalation 1-2x high topical anti- inhalation for the hypersensitivity to mouth and throat. • Assess pt’s condition before
daily inflammatory potency. prophylaxis of the fluticasone Hoarseness. Suppression of therapy.
It has a strong affinity symptoms of asthma; propionate or any adrenal function, growth • Assess active infection and
for and agonist activity also by nasal spray ingredient in the retardation in children. assess if
at human for allergic rhinitis. formulation. immunocompromised
glucocorticoid • Assess pulmonary and cardiac
receptors. status.
• Monitor possible adverse
reaction
PLANNING
• Store at controlled room
temperature away from direct
sunlight
IMPLEMENTATION
• Advise that the drug is for
long term maintenance
• Instruct proper way of drug
inhalation
• Instruct to rinse mouth after
each inhalation to prevent oral
candidiasis.
• Instructs to immediately
report decreasing effect of
inhaled beta agonist
• Instruct to report drug
induced adverse reaction
DRUG NAME DOSAGE MECHANISM OF INDICATION CONTRA- ADVERSE REACTIONS NURSING
ACTION INDICATION RESPONSIBILITIES
Ampicillin 1-2 g a day in Interferes with cell Treatment of Hypersensitivity to Thromboplebitis at injection ASSESSMENT
divided doses wall synthesis of respiratory tract and penicillin, site, dizziness, fatigue, • Obtain patients history
every 6 hours susceptible organisms, soft tissue infection. cephalosporin or insomia, reversible • Assess signs and symptoms of
preventing bacterial Bacterial meningitis. imipenem. hyperactivity infection
multiplication, it also Septicemia and • Obtain baseline data of WBC
renders cell wall gonoccocal infection • Obtain C&S before drug
osmotically unstable caused by susceptible therapy
and burst due to microorganisms; • Assess sensitivity reactions
osmotic pressure. prophylaxis in rape
• Assess allergic reactions
Deactivated by beta- victims and for
lactamase, an enzyme bacterial • Monitor renal function
produced by resistant. endocarditis. • Monitor blood studies
• Assess for overgrowth of
infection
PLANNING
• Give in even doses round the
clock
• IM route reconstitute with
125mg/0.9 – 1.2mL;
500mg/1.2 – 1.8mL; 1g/2.4 –
7.4mL; 2g/6.8mL
• Give by direct IV over 3-5
mins in lower dosage
IMPLEMENTATION
• Instruct to take medications as
prescribed
• Advise to monitor adverse
reaction
• Instruct pt if diarrhea with
blood or pus occur notify
physician
DRUG NAME DOSAGE MECHANISM OF INDICATION CONTRA- ADVERSE REACTIONS NURSING
ACTION INDICATION RESPONSIBILITIES
Budesonide Children: 1- Exerts a local anti Used for Hypersensitivity to Nasal irritation/bleeding; ASSESSMENT
2mg inflammatory effect by management of budesonide. burning; stinging; sneezing; • Obtain patients history
maintenance depression of bronchial asthma and pharingitis. • Assess respiratory status
0.5-1mg migaration of symptomatic • Check for oral candidiasis
Adult: 0.5- polymorphonuclear management of GI: dry mouth, indigestion, • Be alert for bronchospasm
1mg leukocytes and seasonal or perennial rash, face and tongue edema, • Carefully assess presence of
maintenance fibroblasts; reversal of allergic rhinitis. pruritus, bronchospasm. viral infection
0.25-5mg increased capillary
• Regularly assess intraocular
permeability and
pressure
Tubuhaler: lysosomal
PLANNING
400-1600mcg stabilization. It does
divided in 2-4 not suppress • Do not crush, break or chew
divided doses hypothalamus and the capsule
pituitary function. • Store at 15-39 degrees Celsius
(59-86F)
IMPLEMENTATION
• Instruct how to use nasal
inhaler himself
• Teach pt to notify physician
of pharyngitis, nasal bleeding
• Instruct pt not to exceed
recommemded dosage;
adrenal suppression may
occur
• Instruct pt to prevent
exposure to infections,
especially viral.
Pamantasan ng Lungsod ng Pasay
College of Nursing and School of Midwifery
EMPHYSEMA
Submitted by:
Madeliene Kae R. Estanislao
BSN IV-2
Submitted to:
Mrs. Bautista